Mind Medicine (MindMed) Inc. financial data

Symbol
MNMD on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
One World Trade Center, Suite 8500, New York, NY
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 525 % +9.67%
Debt-to-equity 33.8 % +29.7%
Return On Equity -53 % +16.6%
Return On Assets -39.6 % +21.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 73.3M shares +82.9%
Common Stock, Shares, Outstanding 81.6M shares +103%
Entity Public Float 140M USD -48.5%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 77.9M shares +96.1%
Weighted Average Number of Shares Outstanding, Diluted 80.2M shares +102%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 55.1M USD +11.5%
General and Administrative Expense 38.6M USD +6.7%
Operating Income (Loss) -93.7M USD -9.46%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.5M USD +4.14%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -97.8M USD -27.4%
Earnings Per Share, Basic -1.98 USD/shares -5.32%
Earnings Per Share, Diluted -2.25 USD/shares -19.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 295M USD +151%
Assets, Current 299M USD +149%
Operating Lease, Right-of-Use Asset 200K USD
Goodwill 19.9M USD 0%
Other Assets, Noncurrent 493K USD +115%
Assets 320M USD +126%
Accounts Payable, Current 2.15M USD -72%
Accrued Liabilities, Current 8.8M USD -11.7%
Liabilities, Current 33.3M USD +6.78%
Other Liabilities, Noncurrent 15K USD -98.6%
Liabilities 57.6M USD +26.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 821K USD +5.66%
Retained Earnings (Accumulated Deficit) -364M USD -36.7%
Stockholders' Equity Attributable to Parent 262M USD +173%
Liabilities and Equity 320M USD +126%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.6M USD -24.5%
Net Cash Provided by (Used in) Financing Activities 169M USD +28930%
Common Stock, Shares, Issued 81.6M shares +103%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 153M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 434K USD
Deferred Tax Assets, Valuation Allowance 51M USD +41.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 200K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -97.8M USD -27.4%
Deferred Tax Assets, Operating Loss Carryforwards 31.6M USD +24.7%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 200K USD
Amortization of Intangible Assets 1.3M USD -59.3%
Deferred Tax Assets, Net of Valuation Allowance 114K USD +256%
Share-based Payment Arrangement, Expense 17.1M USD +29.9%
Interest Expense 727K USD +122%